Population pharmacokinetics of amikacin in patients with haematological malignancies

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 2, 1999, Pages 235-242

  Romano, S ^a,c   Fdez De Gatta, M ^a   Calvo, M V ^b   Caballero, D ^b   Dominguez Gil, A ^a,b   Lanao, J M ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; CREATININE; VANCOMYCIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BACTERIAL INFECTION; BODY WEIGHT; COMPARTMENT MODEL; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYPOALBUMINEMIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PARENTERAL NUTRITION;

ADULT; AGED; AMIKACIN; ANTI-BACTERIAL AGENTS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 0032771862     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.2.235     Document Type: Article

References (30)

1. Bodey, G. P. (1984). Antibiotics in patients with neutropenia. Archives of Internal Medicine 144, 1845-51.
2. Hughes, W. T., Armstrong, D., Bodey, G. P., Feld, R., Mandell, G. L, Meyers, J. D. et al. (1990). Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Journal of Infectious Diseases 161, 381-96.
3. Pizzo, P. A. (1993). Management of fever in patients with cancer and treatment-induced neutropenia. New England Journal of Medicine 328, 1323-32.
4. EORTC International Antimicrobial Therapy Cooperative Group. (1993). Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Annals of Internal Medicine 119, 584-93.
5. Manny, R. P. & Hutson, P. R. (1986). Aminoglycoside volume of distribution in hematology-oncology patients. Clinical Pharmacy 5, 629-32.
6. Higa, G. M. & Murray, W. E. (1987). Alterations in aminoglycoside pharmacokinetics in patients with cancer. Clinical Pharmacy 6, 963-6.
7. Phillips, J. K., Spearing, R. L., Crome, D. J. & Davies, J. M. (1988). Gentamicin volumes of distribution in patients with hematologic disorders. New England Journal of Medicine 319, 1290.
8. Hary, L., Andrejak, M., Bernaert, F. R. & Desablens, B. (1989). Pharmacokinetics of amikacin in neutropenic patients. Current Therapeutic Research 46, 821-7.
9. Kaojarern, S., Maoleekoonpairoj, S. & Atichartakarn, V. (1989). Pharmacokinetics of amikacin in hematologic malignancies. Antimicrobial Agents and Chemotherapy 33, 1406-8.
10. Zeitany, R. G., El Saghir, N. S., Santhosh-Kumar, C. R. 26amp; Sigmon, M. A. (1990). Increased aminoglycoside dosage requirements in hematologic malignancy. Antimicrobial Agents and Chemotherapy 34, 702-8.
11. Davis, R. L., Lehmann, D., Stidley, C. A. & Neidhart, J. (1991). Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy. Antimicrobial Agents and Chemotherapy 35, 944-7.
12. Bertino, J. S., Booker, L. A., Franck, P. & Rybicki, B. (1991). Gentamicin pharmacokinetics in patients with malignancies. Antimicrobial Agents and Chemotherapy 35, 1501-3.
13. Ho, K. K., Bryson, S. M., Thiessen, J. J., Greenberg, M. L., Einarson, T. R. & Leson, C. L. (1995). The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients. Pharmacotherapy 15, 754-64.
14. Jacobson, P. A., West, N. J., Price, J. & Hutchinson, R. J. (1997). Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients. The Annals of Pharmacotherapy 31, 1127-31.
15. Cockcroft, D. W. & Gault, M. H. (1976). Prediction of creatinine clearance from serum creatinine. Nephron 16, 31-41.
16. Beal, S. L. & Sheiner, L. B. (1989). NONMEM User's Guides. San Francisco: NONMEM Project Group. University of California, San Francisco, CA.
17. Sheiner, L. B., Rosenberg, B. & Marathe, V. V. (1977). Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. Journal of Pharmacokinetics and Biopharmaceutics 5, 445-79.
18. Yamaoka, K., Nakagawa, T. & Uno, T. (1978). Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics 6, 165-75.
19. Sheiner, L. B. & Beal, S. L. (1981). Some suggestions for measuring predictive performance. Journal of Pharmacokinetics and Biopharmaceutics 9, 503-12.
20. Vozeh, S., Maitre, P. O. & Stanski, D. R. (1990). Evaluation of population (NONMEM) pharmacokinetic parameter estimates. Journal of Pharmacokinetics and Biopharmaceutics 18, 161-73.
21. Maitre, P. O., Vozeh, S., Heykants, J., Thomson, D. A. & Stanski, D. R. (1987). Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients. Anesthesiology 66, 3-12.
22. Lentner, C. (1982). Geigy Scientific Tables. West Caldwell, New Jersey.
23. Radomski, K. M., Davis, G. A. & Chandler, M. H. (1997). General versus subpopulation values in Bayesian prediction of aminoglycoside pharmacokinetics in hematology-oncology patients. American Journal of Health-System Pharmacy 54, 541-4.
24. Samara, E. & Granneman, E. R. (1997). Role of population pharmacokinetics in drug development. A pharmaceutical industry perspective. Clinical Pharmacokinetics 32, 294-312.
25. Debord, J., Charmes, J. P., Marquet, P., Merle, L. & Lachartre, G. (1995). Population pharmacokinetics of amikacin in geriatric patients studied by NPEM algorithm. International Journal of Clinical Pharmacology and Therapeutics 9, 57-61.
26. Romano, S., Fdez de Gatta, M. M., Calvo, M. V., Mendez, E., Dominguez-Gil, A. & Lanao, J. M. (1998). Influence of clinical diagnosis in the population pharmacokinetics of amikacin in intensive care unit patients. Clinical Drug Investigation 15, 435-44.
27. Murry, D. J., Synold, T. W., Pui, C. & Rodman, J. H. (1995). Renal function and methotrexate clearance in children with newly diagnosed leukemia. Pharmacotherapy 15, 144-9.
28. Etzel, J. V., Nafziger, A. N. & Bertino, J. S. (1992). Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia. Antimicrobial Agents and Chemotherapy 36, 679-81.
29. Cheney, C. L., Abson, K. G., Aker, S. N., Lenssen, P., Cunningham, B. A., Buergel, N. S. et al. (1987). Body composition changes in marrow transplant recipients receiving total patenteral nutrition. Cancer 59, 1515-9.
30. Kosirog, J. L., Rospond, R. M., Destache, C. & Hall, P. (1993). Aminoglycoside forecasting in neutropenic patients with cancer. Clinical Pharmacokinetics 24, 79-87.